"Lamivudine/pharmacokinetics"[MAJR] - Search Results

Year	Number of Results
1995	1
1996	3
1997	3
1998	5
1999	6
2000	7
2001	6
2002	6
2003	3
2004	6
2005	4
2006	4
2007	13
2008	8
2009	8
2010	11
2011	7
2012	9
2013	9
2014	6
2015	5
2016	5
2017	6
2018	8
2019	2
2020	7
2021	1
2023	1
2024	3

1

Tenofovir, emtricitabine, lamivudine and dolutegravir concentrations in plasma and urine following drug intake cessation in a randomized controlled directly observed pharmacokinetic trial to aid point-of-care testing.

Else LJ, Dickinson L, Edick S, Zyhowski A, Ho K, Meyn L, Dilly-Penchala S, Thompson B, Shaw V, Khoo S, Brand RM. Else LJ, et al. J Antimicrob Chemother. 2024 Jul 1;79(7):1597-1605. doi: 10.1093/jac/dkae147. J Antimicrob Chemother. 2024. PMID: 38758205 Free PMC article. Clinical Trial.

2

Population pharmacokinetic modeling of dolutegravir/lamivudine to support a once-daily fixed-dose combination regimen in virologically suppressed adults living with HIV-1.

Chandasana H, Singh R, Adkison K, Ait-Khaled M, Pene Dumitrescu T. Chandasana H, et al. Antimicrob Agents Chemother. 2024 May 2;68(5):e0150423. doi: 10.1128/aac.01504-23. Epub 2024 Apr 8. Antimicrob Agents Chemother. 2024. PMID: 38587380 Free PMC article. Clinical Trial.

3

Bioequivalence and Pharmacokinetics Study of Two Zidovudine/Lamivudine Tablets in Chinese Healthy Volunteers.

Huang X, Wang G, Huang J, Liang W, Guan H, Liu H, Deng Y, You Y, Zhang B. Huang X, et al. Clin Pharmacol Drug Dev. 2024 Jan;13(1):14-20. doi: 10.1002/cpdd.1335. Epub 2023 Nov 20. Clin Pharmacol Drug Dev. 2024. PMID: 37986709 Clinical Trial.

4

Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092.

Owor M, Tierney C, Ziemba L, Browning R, Moye J, Graham B, Reding C, Costello D, Norman J, Wiesner L, Hughes E, Whalen ME, Purdue L, Mmbaga BT, Kamthunzi P, Kawalazira R, Nathoo K, Bradford S, Coletti A, Aweeka F, Musoke P. Owor M, et al. Pediatr Infect Dis J. 2021 May 1;40(5):446-452. doi: 10.1097/INF.0000000000003055. Pediatr Infect Dis J. 2021. PMID: 33464021 Free PMC article. Clinical Trial.

5

Zidovudine and lamivudine reach higher concentrations in ventricular than in lumbar human cerebrospinal fluid.

Eggers C, Hoetelmans R, Läer S. Eggers C, et al. AIDS. 2020 Nov 1;34(13):1883-1889. doi: 10.1097/QAD.0000000000002626. AIDS. 2020. PMID: 32694416

6

The effect of veno-arterial extracorporeal oxygenation and nasogastric tube administration on the pharmacokinetic profile of abacavir, lamivudine and dolutegravir: a case report.

Blackman AL, Heil EL, Devanathan AS, Pandit NS. Blackman AL, et al. Antivir Ther. 2020;25(2):115-119. doi: 10.3851/IMP3355. Antivir Ther. 2020. PMID: 32341207 Free PMC article.

7

Influence of a herbal preparation on the pharmacokinetics of highly active antiretroviral therapy drugs in rats.

Su Q, Lu Z, Tang Y, Wei S, Zhou Z, Jiang F. Su Q, et al. Pak J Pharm Sci. 2020 Jan;33(1):49-52. Pak J Pharm Sci. 2020. PMID: 32122830

8

Comparative Bioavailability of Oral Granule Formulations of the HIV Antiretroviral Drugs Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate.

Yee KL, DiBenedetto A, Fan L, Khalilieh S, Triantafyllou I, Vallee MH, Fackler P, Stoch SA, Iwamoto M. Yee KL, et al. AAPS PharmSciTech. 2020 Feb 13;21(3):91. doi: 10.1208/s12249-020-1630-6. AAPS PharmSciTech. 2020. PMID: 32060665 Clinical Trial.

9

Bioequivalence and Food Effect Assessment of 2 Fixed-Dose Combination Formulations of Dolutegravir and Lamivudine.

Dumitrescu TP, Peddiraju K, Fu C, Bakshi K, Yu S, Zhang Z, Tenorio AR, Spancake C, Joshi S, Wolstenholme A, Adkison K. Dumitrescu TP, et al. Clin Pharmacol Drug Dev. 2020 Feb;9(2):189-202. doi: 10.1002/cpdd.740. Epub 2019 Nov 14. Clin Pharmacol Drug Dev. 2020. PMID: 31724343 Free PMC article. Clinical Trial.

10

Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging people living with HIV.

Courlet P, Stader F, Guidi M, Alves Saldanha S, Stoeckle M, Cavassini M, Battegay M, Buclin T, Decosterd LA, Marzolini C; Swiss HIV Cohort Study. Courlet P, et al. AIDS. 2020 Jan 1;34(1):103-108. doi: 10.1097/QAD.0000000000002372. AIDS. 2020. PMID: 31490233

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

144 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Results by year